Oral phytate supplementation on the progression of mild cognitive impairment, brain iron deposition and diabetic retinopathy in patients with type 2 diabetes: a concept paper for a randomized double blind placebo controlled trial (the PHYND trial).

MLA

Pujol, Antelm, et al. “Oral Phytate Supplementation on the Progression of Mild Cognitive Impairment, Brain Iron Deposition and Diabetic Retinopathy in Patients with Type 2 Diabetes: A Concept Paper for a Randomized Double Blind Placebo Controlled Trial (the PHYND Trial).” Frontiers in Endocrinology, June 2024, pp. 01-13. EBSCOhost, https://doi.org/10.3389/fendo.2024.1332237.

APA

Pujol, A., Sanchis, P., Tamayo, M. I., Nicolau, J., Grases, F., Espino, A., Estremera, A., Rigo, E., Amengual, G. J., Rodríguez, M., Ribes, J. L., Gomila, I., Simó-Servat, O., & Masmiquel, L. (2024). Oral phytate supplementation on the progression of mild cognitive impairment, brain iron deposition and diabetic retinopathy in patients with type 2 diabetes: a concept paper for a randomized double blind placebo controlled trial (the PHYND trial). Frontiers in Endocrinology, 01-13. https://doi.org/10.3389/fendo.2024.1332237

Chicago

Pujol, Antelm, Pilar Sanchis, María I. Tamayo, Joana Nicolau, Félix Grases, Ana Espino, Ana Estremera, et al. 2024. “Oral Phytate Supplementation on the Progression of Mild Cognitive Impairment, Brain Iron Deposition and Diabetic Retinopathy in Patients with Type 2 Diabetes: A Concept Paper for a Randomized Double Blind Placebo Controlled Trial (the PHYND Trial).” Frontiers in Endocrinology, June, 01-13. doi:10.3389/fendo.2024.1332237.